Healthcare ❯ Pharmaceuticals

Manufacturing

Biologics Research and Development Facilities Domestic Production Sterile Products Injectable Drugs Product Development U.S. Industry Respiratory Medicines Investments

Amgen Invests $300 Million to Expand Puerto Rico Biologics Plant

The move signals a push to shore up U.S. drug supply chains under new import‑tariff pressure.

AbbVie to Build $1.4 Billion Injectable-Medicines Campus in Durham, N.C.

Novartis to Build 46,000‑Square‑Foot Radioligand Therapy Plant in Denton, Texas

Novartis Picks North Carolina for Flagship End-to-End Drug Manufacturing Hub

Novartis Opens Carlsbad Radioligand Therapy Plant as U.S. Buildout Accelerates

Lupin to Build $250 Million Respiratory Drug Plant in Coral Springs, Florida

Amanta Healthcare IPO Fully Subscribed On Day One As Bidding Enters Day Two

J&J Commits $2 Billion to 10-Year Fujifilm Deal for North Carolina Biologics Hub

Johnson & Johnson Launches $55 Billion U.S. Manufacturing and Research Expansion

Eli Lilly Invests $9 Billion to Boost Production of Weight Loss Drugs

AstraZeneca to Invest $1.5 Billion in Singapore Cancer Drug Plant